Suggestions
Nora Khanarian
Professional Background
Nora Khanarian is a highly accomplished professional in the field of biomedical engineering and oncology, currently serving as the Senior Director of Oncology Early Commercial Development at Pfizer. With a robust background that spans several prestigious positions within the pharmaceutical industry, Nora has developed a comprehensive understanding of commercial strategy and development in oncology. Her career trajectory reflects a strong commitment to advancing the field of biomedical engineering while ensuring the successful translation of scientific research into impactful therapeutic solutions.
Nora's tenure at Pfizer has seen her rise through the ranks, showcasing her expertise in oncology commercial assessment and forecasting. Prior to her current role, she was the Director of Oncology Commercial Assessment and Forecasting Excellence, and before that, she served as a Senior Manager in the same department. Her responsibilities have encompassed developing strategic insights that guide decision-making processes in early commercial development, ultimately leading to the improved efficacy and success of oncology portfolio products.
Before joining Pfizer, Nora honed her skills at Purdue Pharma L.P., where she served as both Associate Director and Senior Manager of Business Development and Commercial Assessments. Her work there focused on evaluating market potential and providing crucial market insights to enhance strategic initiatives. Earlier in her career, she was also a Life Sciences Specialist and Consultant at L.E.K. Consulting, where she supported major life sciences companies in optimizing business strategies, facilitating her growth into her current leadership roles.
Education and Achievements
Nora's educational background is as impressive as her professional journey. She earned her Bachelor of Science in Engineering in Nanotechnology, Materials Science, and Bioengineering from the University of Pennsylvania, laying a solid foundation in engineering and scientific principles. Her passion for research and innovation led her to pursue a Master of Science and later a Doctor of Philosophy in Biomedical Engineering at Columbia Engineering, where she contributed to cutting-edge research in the field, thus aligning her academic pursuits with her professional aspirations.
Nora's collective education and professional experience position her at the forefront of developments in oncology and biomedical engineering. She has cultivated a wealth of knowledge and expertise that is instrumental in driving forward-thinking strategies in the pharmaceutical industry.
Achievements
Throughout her career, Nora has achieved numerous accolades that underscore her leadership and innovative mindset within the biomedical and pharmaceutical landscapes. From her prominent leadership at Pfizer, spearheading initiatives in early commercial development, to her contributions to market assessments at Purdue Pharma, Nora has consistently demonstrated an ability to bridge the gap between scientific research and market execution.
Her roles have not only positioned her as a key player in oncology but also highlighted her dedication to fostering collaboration among cross-functional teams and stakeholders, ensuring that scientific innovations can reach patients who need them the most. Nora's leadership, strategic foresight, and analytical approach have made her a respected voice in the industry, reflecting her unwavering commitment to transforming biomedical advancements into tangible health solutions.